All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
REGN total return snapshot: REGN returned +21.70% over the past year and −5.52% YTD, with dividends reinvested. Since Apr. 2, 1991, REGN is up +3,371.37% in nominal total return, or +10.51%/yr, and is currently −38.98% below its total-return high on Aug. 27, 2024.
Data ending Mon Oct. 5, 2026
| Tue 1991-04-02💬 to Mon 2026-10-05 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| REGN × |
+3,371.37%
+10.51%/yr |
+16.93%/yr
R2=0.823 |
||||
| Regeneron Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Tue 1991-04-02💬 to Mon 2026-10-05 |
Start
Value |
End
Value |
|---|---|---|
| REGN × |
$10,000.00
1991-04-02 |
$347,136.54
2026-10-05 |
| YTD | YoY | |
|---|---|---|
| REGN × | −5.52% | +21.70% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| REGN × |
−38.98%
on 2026-10-05 from 2024-08-27 peak |
−91.81%
on 2005-04-14 from 2000-02-29 peak |
| Period ending Mon 2026-10-05 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| REGN × | +21.70% |
−27.60% −14.91%/yr |
−11.77% −4.09%/yr |
+33.11% +5.89%/yr |
+86.79% +6.45%/yr |
| Year | REGN |
|---|---|
| 2026 (YTD) | −5.52% |
| 2025 | +8.96% |
| 2024 | −18.90% |
| 2023 | +21.73% |
| 2022 | +14.25% |
| 2021 | +30.72% |
| 2020 | +28.66% |
| 2019 | +0.53% |
| 2018 | −0.65% |
| 2017 | +2.42% |
| 2016 | −32.38% |
| 2015 | +32.33% |
| 2014 | +49.05% |
| 2013 | +60.89% |
| 2012 | +208.62% |
| 2011 | +68.84% |
| 2010 | +35.77% |
| 2009 | +31.70% |
| 2008 | −23.97% |
| 2007 | +20.33% |
| 2006 | +26.23% |
| 2005 | +72.64% |
| 2004 | −37.39% |
| 2003 | −20.53% |
| 2002 | −34.27% |
| 2001 | −20.15% |
| 2000 | +176.59% |
| 1999 | +72.88% |
| 1998 | −13.87% |
| 1997 | −46.90% |
| 1996 | +26.47% |
| 1995 | +324.99% |
| 1994 | −80.64% |
| 1993 | +29.17% |
| 1992 | −33.79% |
| 1991 | −14.20% |
